DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Lenacapavir
Lenacapavir
HPTN 083 – Injectable Cabotegravir (CAB) for Prep
Long-Acting Subcutaneous Lenacapavir Dosed Every 6 Months
What's New in Hiv? Highlights & New Data on Hiv Treatment a Presentation for Healthtrust Members June 18, 2021
Guidelines for the Use of Antiretroviral Agents in Adults and Adolescent Living With
Croi 2021 Program Committee
Interactions of HIV-1 Capsid with Host Factors and Their Implications for Developing Novel Therapeutics
Access the 2020 Prioritisation Report
Lenacapavir Resistance Analysis in a Phase 1B Clinical Proof-Of-Concept
CROI 2021 Updates ART Strategies in Global Settings (And a Little Bit of COVID!)
NEJM Editorial
Gilead Sciences Presents Data from HIV Research and Development Programs at HIV Glasgow 2020
Novel Drugs and Their Combinations Used for Treating Aids
HIV and COVID-19 No 8
Pharmacy Residency Hiv Ambulatory Care Rotation
Overview of Antiretrovirals for HIV Treatment
Type of the Paper (Article
Management of the Treatment-Experienced Patient
J. Boyd Francis, M.D. Lectureship HIV Primary Care: an Update on Management and Prevention
Top View
Evolving Access Pathways for Long-Acting HIV Prevention Products
HIV and COVID-19 No 7
Q1 2021 Presentation
Download #2021007
JP Morgan Healthcare Conference Daniel O’Day Chairman and Chief Executive Officer
Bioactive Compound Library Plus (96-Well)
Hiv Medicine Pricing & Access Issues, 2020
Antiretroviral and Directly Acting Antiviral Drug Metabolism and Transporter Characteristics (Summary)
Update on Long-Acting Arvs
Pipeline Report » 2021 Antiretroviral Therapy PIPELINE REPORT 2021
Antiretroviral Therapy PIPELINE REPORT 2020
Islatravir Clinical Program Overview for Media Background June 2021
Drug Repurposing Compound Library Plus (96-Well)
Viral Load Reduction in SHIV-Positive Nonhuman Primates Via Long-Acting Subcutaneous Tenofovir Alafenamide Fumarate Release from a Nanofluidic Implant
Rxoutlook® 1St Quarter 2021
Zusammenfassende Dokumentation
Merck and Gilead Announce an HIV Partnership